Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O Plancke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1988
Aspects of cholesterol metabolism in normal and hypercholesterolemic Syrian hamsters. Influence of fenofibrateM O Plancke, P Olivier, V Clavey, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1989
Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamstersZ Moussavi, M O Plancke, P Olivier, et al.
Atherosclerosis|November 1, 1988
Effects of fenofibrate on lipoprotein metabolism and fatty acid distribution in Zucker ratsP Olivier, M O Plancke, N Theret, et al.
Atherosclerosis|March 1, 1988
Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screeningP Olivier, M O Plancke, D Marzin, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1988
Aspects of cholesterol metabolism in normal and hypercholesterolemic Syrian hamsters. Influence of fenofibrateM O Plancke, P Olivier, V Clavey, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1989
Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamstersZ Moussavi, M O Plancke, P Olivier, et al.
Atherosclerosis|November 1, 1988
Effects of fenofibrate on lipoprotein metabolism and fatty acid distribution in Zucker ratsP Olivier, M O Plancke, N Theret, et al.
Atherosclerosis|March 1, 1988
Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screeningP Olivier, M O Plancke, D Marzin, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Pageof 1